Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Rejuveron funds $29 million for degenerative eye disease

Rejuveron increases to near-majority stake in Endogena to progress treatments for degenerative diseases of the eye.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.